首页> 外文OA文献 >Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

【2h】

Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

机译：间歇性化疗加间歇性或连续性西妥昔单抗用于一线治疗KRAS野生型晚期大肠癌（COIN-B）：一项随机的2期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wasan Harpreet; Meade Angela M; Adams Richard; Wilson Richard; Pugh Cheryl; Fisher David; Sydes Benjamin; Madi Ayman; Sizer Bruce; Lowdell Charles; Middleton Gary; Butler Rachel; Kaplan Richard; Maughan Tim;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): A randomised phase 2 trial [J] . WasanH., MeadeA.M., AdamsR., The lancet oncology . 2014,第6期

机译：间歇性化疗加间歇性或连续西妥昔单抗用于一线治疗KRAS野生型晚期结直肠癌（COIN-B）患者：一项随机的2期临床试验
2. Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. [J] . Adams RA, Meade AM, Seymour MT, The lancet oncology . 2011,第7期

机译：间歇性与连续性奥沙利铂和氟嘧啶联合化疗用于晚期大肠癌的一线治疗：3期MRC COIN随机试验的结果。
3. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials [J] . BokemeyerC., CutsemE.V., RougierP., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2012,第10期

机译：西妥昔单抗作为KRAS野生型转移性结直肠癌一线治疗的化学疗法：CRYSTAL和OPUS随机临床试验的汇总分析
4. Towards automatic patient selection for chemotherapy in colorectal cancer trials [C] . Alexander Wright, Derek Magee, Philip Quirke, Conference on digital pathology . 2014

机译：在大肠癌试验中寻求化学疗法的自动患者选择
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial [O] . Richard A Adams, Angela M Meade, Matthew T Seymour, -1

机译：间歇性与连续性奥沙利铂和氟嘧啶联合化疗治疗晚期大肠癌的一线治疗：MRC COIN 3期随机试验的结果
7. Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial [O] . Wasan, Harpreet, Meade, Angela M, Adams, Richard, 2014

机译：间歇性化疗加间歇性或连续性西妥昔单抗用于一线治疗KRAS野生型晚期大肠癌（COIN-B）：一项随机的2期临床试验

Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

著录项

引文网络

相似文献

相关主题

期刊订阅